Summary
This filing is an amendment to UnitedHealth Group's (UNH) quarterly report for the period ending March 31, 2006. The primary focus of this amendment is the restatement of previously issued financial statements due to accounting errors related to historic stock option practices. The company has identified material weaknesses in its internal controls over financial reporting concerning stock option plan administration. While the core business operations appear robust with significant revenue growth driven by acquisitions and new programs like Medicare Part D, investors should be aware that previously reported financial figures are no longer reliable and are subject to revision. The company is cooperating with regulatory inquiries and facing litigation related to these stock option issues, which could have material adverse effects.
Key Highlights
- 1Restatement of financial statements for the period ended March 31, 2006, and prior periods, primarily due to stock option accounting errors.
- 2Identification of a material weakness in internal control over financial reporting related to stock option plan administration, accounting, and disclosure.
- 3Significant year-over-year revenue growth of 58% in Q1 2006, largely driven by acquisitions (notably PacifiCare) and the launch of the Medicare Part D program.
- 4Diluted net earnings per share increased by 15% to $0.63 in Q1 2006 compared to $0.55 in Q1 2005.
- 5Increased cash flows from operations to $2.9 billion in Q1 2006, up from $1.1 billion in Q1 2005.
- 6The company is subject to ongoing regulatory inquiries (SEC, IRS, U.S. Attorney, State AG) and shareholder litigation related to its historical stock option practices.
- 7Moody's and AM Best downgraded credit ratings due to concerns over stock option practices, although the company believes it still has adequate borrowing capacity.